Published in J Physiol on January 10, 2003
Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev (2010) 11.25
A transmembrane accessory subunit that modulates kainate-type glutamate receptors. Neuron (2009) 2.07
Distinct functions of kainate receptors in the brain are determined by the auxiliary subunit Neto1. Nat Neurosci (2011) 2.00
Ionotropic glutamate receptors & CNS disorders. CNS Neurol Disord Drug Targets (2008) 1.27
Neto1 is an auxiliary subunit of native synaptic kainate receptors. J Neurosci (2011) 1.26
Defined criteria for auxiliary subunits of glutamate receptors. J Physiol (2011) 1.14
Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iGluR5 induced by the high affinity agonist dysiherbaine and the functional antagonist 8,9-dideoxyneodysiherbaine. J Biol Chem (2009) 1.13
Neto1 and Neto2: auxiliary subunits that determine key properties of native kainate receptors. J Physiol (2012) 1.10
Dancing partners at the synapse: auxiliary subunits that shape kainate receptor function. Nat Rev Neurosci (2012) 1.09
Regulation of synaptic transmission by ambient extracellular glutamate. Neuroscientist (2007) 1.05
KRIP6: a novel BTB/kelch protein regulating function of kainate receptors. Mol Cell Neurosci (2007) 1.04
A nondesensitizing kainate receptor point mutant. Mol Pharmacol (2009) 1.00
Zinc potentiates GluK3 glutamate receptor function by stabilizing the ligand binding domain dimer interface. Neuron (2012) 0.95
Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia. Schizophr Res (2013) 0.95
Modulation of non-NMDA receptor gating by auxiliary subunits. J Physiol (2014) 0.91
Modulation of ionotropic glutamate receptor function by vertebrate galectins. J Physiol (2014) 0.87
Crosslinking the ligand-binding domain dimer interface locks kainate receptors out of the main open state. J Physiol (2013) 0.85
The BTB/kelch protein, KRIP6, modulates the interaction of PICK1 with GluR6 kainate receptors. Neuropharmacology (2008) 0.85
Concanavalin-A reports agonist-induced conformational changes in the intact GluR6 kainate receptor. J Physiol (2006) 0.82
Trafficking of kainate receptors. Membranes (Basel) (2014) 0.79
Retour aux sources: defining the structural basis of glutamate receptor activation. J Physiol (2014) 0.79
Modulation of GluK2a subunit-containing kainate receptors by 14-3-3 proteins. J Biol Chem (2013) 0.78
From toxins targeting ligand gated ion channels to therapeutic molecules. Toxins (Basel) (2011) 0.77
Membrane-associated guanylate kinase scaffolds organize a horizontal cell synaptic complex restricted to invaginating contacts with photoreceptors. J Comp Neurol (2016) 0.75
Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron (2000) 6.22
PDZ domains and the organization of supramolecular complexes. Annu Rev Neurosci (2001) 5.92
The rat brain postsynaptic density fraction contains a homolog of the Drosophila discs-large tumor suppressor protein. Neuron (1992) 5.26
Structure of a glutamate-receptor ligand-binding core in complex with kainate. Nature (1998) 4.14
Binding of the inward rectifier K+ channel Kir 2.3 to PSD-95 is regulated by protein kinase A phosphorylation. Neuron (1996) 3.75
The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature (1998) 3.41
PDZ domains in synapse assembly and signalling. Trends Cell Biol (2000) 2.96
Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A. Neuron (1993) 2.78
PDZ domains bind carboxy-terminal sequences of target proteins. Trends Biochem Sci (1996) 2.42
SAP90, a rat presynaptic protein related to the product of the Drosophila tumor suppressor gene dlg-A. J Biol Chem (1993) 2.17
Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acid-binding proteins. Neuron (1994) 2.15
Molecular organization of the postsynaptic specialization. Proc Natl Acad Sci U S A (2001) 1.92
Glutamate receptor channels in rat DRG neurons: activation by kainate and quisqualate and blockade of desensitization by Con A. Neuron (1990) 1.89
Concanavalin A selectively reduces desensitization of mammalian neuronal quisqualate receptors. Proc Natl Acad Sci U S A (1989) 1.82
Ligand-gated ion channel interactions with cytoskeletal and signaling proteins. Annu Rev Physiol (2000) 1.82
SAP90 binds and clusters kainate receptors causing incomplete desensitization. Neuron (1998) 1.63
Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron (1994) 1.58
Permeation and block of rat GluR6 glutamate receptor channels by internal and external polyamines. J Physiol (1997) 1.50
Control of rat GluR6 glutamate receptor open probability by protein kinase A and calcineurin. J Physiol (1997) 1.49
Clustering and enhanced activity of an inwardly rectifying potassium channel, Kir4.1, by an anchoring protein, PSD-95/SAP90. J Biol Chem (1997) 1.29
Neuronal inwardly rectifying K(+) channels differentially couple to PDZ proteins of the PSD-95/SAP90 family. J Neurosci (2000) 1.28
Activation and desensitization of hippocampal kainate receptors. J Neurosci (1997) 1.25
Distinct structural requirements for clustering and immobilization of K+ channels by PSD-95. J Gen Physiol (1999) 1.21
Kinetics of homomeric GluR6 glutamate receptor channels. Biophys J (1996) 1.21
Activity-dependent modulation of glutamate receptors by polyamines. J Neurosci (1998) 1.21
Rapid redistribution of the postsynaptic density protein PSD-Zip45 (Homer 1c) and its differential regulation by NMDA receptors and calcium channels. J Neurosci (2001) 1.20
Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid- and kainate-preferring glutamate receptors. Mol Pharmacol (1993) 1.19
Synaptic proteins and the assembly of synaptic junctions. Trends Cell Biol (1996) 1.17
External anions and cations distinguish between AMPA and kainate receptor gating mechanisms. J Physiol (2002) 1.15
Functional stoichiometry of glutamate receptor desensitization. J Neurosci (2002) 1.15
Activation and desensitization properties of native and recombinant kainate receptors. Neuropharmacology (1999) 1.11
The PDZ1 domain of SAP90. Characterization of structure and binding. J Biol Chem (2001) 1.09
beta 1-adrenergic receptor association with the synaptic scaffolding protein membrane-associated guanylate kinase inverted-2 (MAGI-2). Differential regulation of receptor internalization by MAGI-2 and PSD-95. J Biol Chem (2001) 1.08
N-Glycosylation is not a prerequisite for glutamate receptor function but Is essential for lectin modulation. Mol Pharmacol (1997) 1.07
Lectin-induced inhibition of desensitization of the kainate receptor GluR6 depends on the activation state and can be mediated by a single native or ectopic N-linked carbohydrate side chain. J Neurosci (1999) 1.04
A voltage-clamp study of isolated stingray horizontal cell non-NMDA excitatory amino acid receptors. J Neurophysiol (1989) 0.94
Desensitization of kainate receptors by kainate, glutamate and diastereomers of 4-methylglutamate. Neuropharmacology (1997) 0.91
The effect of lectins on desensitisation of locust muscle glutamate receptors. Brain Res (1985) 0.85
Differential effects of lectins on recombinant glutamate receptors. Eur J Pharmacol (1995) 0.82
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27
A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature (2009) 18.39
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature (2011) 13.30
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature (2011) 13.18
Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA (2009) 13.00
International study of the prevalence and outcomes of infection in intensive care units. JAMA (2009) 11.57
Mutational processes molding the genomes of 21 breast cancers. Cell (2012) 11.22
The life history of 21 breast cancers. Cell (2012) 10.59
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33
A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med (2008) 7.73
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study. J Clin Oncol (2007) 7.67
Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med (2003) 7.32
A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer. J Clin Oncol (2008) 5.56
C.A.U.S.E.: Cardiac arrest ultra-sound exam--a better approach to managing patients in primary non-arrhythmogenic cardiac arrest. Resuscitation (2007) 5.04
Structural basis for partial agonist action at ionotropic glutamate receptors. Nat Neurosci (2003) 4.55
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol (2003) 3.31
Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles. J Physiol (2005) 2.90
Accelerated corneal crosslinking concurrent with laser in situ keratomileusis. J Cataract Refract Surg (2012) 2.72
Effect of complete epithelial debridement before riboflavin-ultraviolet-A corneal collagen crosslinking therapy. J Cataract Refract Surg (2008) 2.66
Clinician predictions of intensive care unit mortality. Crit Care Med (2004) 2.65
Activation of NR1/NR2B NMDA receptors. Nat Neurosci (2003) 2.47
Optical coherence tomography may be used to predict visual acuity in patients with macular edema. Invest Ophthalmol Vis Sci (2011) 2.45
Activated protein C and septic shock: a propensity-matched cohort study*. Crit Care Med (2012) 2.39
Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer. Cell (2012) 2.37
Mechanism of Ca2+/calmodulin-dependent kinase II regulation of AMPA receptor gating. Nat Neurosci (2011) 2.31
Glutamate receptor gating. Crit Rev Neurobiol (2004) 2.31
Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A (2003) 2.20
Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron (2003) 2.19
Control of NMDA receptor function by the NR2 subunit amino-terminal domain. J Neurosci (2009) 2.19
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study. J Clin Oncol (2008) 2.02
The importance of mosquito behavioural adaptations to malaria control in Africa. Evolution (2013) 1.93
Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med (2008) 1.93
A long-term study of photorefractive keratectomy; 12-year follow-up. Ophthalmology (2004) 1.92
Molecular determinants of proton-sensitive N-methyl-D-aspartate receptor gating. Mol Pharmacol (2003) 1.91
Astrocytic control of synaptic NMDA receptors. J Physiol (2007) 1.85
Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue. J Clin Oncol (2011) 1.84
Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells. Am J Respir Cell Mol Biol (2005) 1.83
Single-cell paired-end genome sequencing reveals structural variation per cell cycle. Nucleic Acids Res (2013) 1.77
Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study. Crit Care Med (2014) 1.72
Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis. Crit Care Med (2012) 1.71
5-year follow-up of LASIK for hyperopia. Ophthalmology (2005) 1.66
CaMKII-independent effects of KN93 and its inactive analog KN92: reversible inhibition of L-type calcium channels. Biochem Biophys Res Commun (2006) 1.63
Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapy. Mol Ther (2010) 1.63
Modulation of the dimer interface at ionotropic glutamate-like receptor delta2 by D-serine and extracellular calcium. J Neurosci (2009) 1.63
A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease. Mol Genet Metab (2007) 1.61
Activation of recombinant NR1/NR2C NMDA receptors. J Physiol (2008) 1.57
Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors. Mol Pharmacol (2007) 1.56
Adenosine A(2A) receptor mediates microglial process retraction. Nat Neurosci (2009) 1.56
Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Mol Pharmacol (2003) 1.55
The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models. Genome Biol (2013) 1.54
Control of assembly and function of glutamate receptors by the amino-terminal domain. Mol Pharmacol (2010) 1.54
Targeting specific PDZ domains of PSD-95; structural basis for enhanced affinity and enzymatic stability of a cyclic peptide. Chem Biol (2004) 1.49
Fourier analysis of induced irregular astigmatism. Photorefractive keratectomy versus laser in situ keratomileusis in a bilateral cohort of hyperopic patients. J Cataract Refract Surg (2003) 1.49
P2Y1 receptor signaling is controlled by interaction with the PDZ scaffold NHERF-2. Proc Natl Acad Sci U S A (2005) 1.48
Effects of ablation diameter on long-term refractive stability and corneal transparency after photorefractive keratectomy. Ophthalmology (2006) 1.47
Open source clinical science for emerging infections. Lancet Infect Dis (2014) 1.47
Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand (2006) 1.47
Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nat Genet (2013) 1.45
Duration of Antimicrobial Treatment for Bacteremia in Canadian Critically Ill Patients. Crit Care Med (2016) 1.44
Important issues in the design and reporting of clinical trials in severe sepsis and acute lung injury. J Crit Care (2008) 1.43
Failure of a discontinuous bend to prevent lens epithelial cell migration in vitro. J Cataract Refract Surg (2002) 1.42
The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc Natl Acad Sci U S A (2003) 1.40
SAP97 and CASK mediate sorting of NMDA receptors through a previously unknown secretory pathway. Nat Neurosci (2009) 1.40
Influence of perceived functional and employment status on cardiopulmonary resuscitation directives. J Crit Care (2003) 1.39
A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors. Nat Commun (2010) 1.38
Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. Cancer Cell (2003) 1.38
Actinfilin is a Cul3 substrate adaptor, linking GluR6 kainate receptor subunits to the ubiquitin-proteasome pathway. J Biol Chem (2006) 1.38
A randomized controlled trial of laparoscopic nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: One-year follow-up. Surg Innov (2006) 1.37
3D collagen orientation study of the human cornea using X-ray diffraction and femtosecond laser technology. Invest Ophthalmol Vis Sci (2009) 1.36
Ionotropic glutamate-like receptor delta2 binds D-serine and glycine. Proc Natl Acad Sci U S A (2007) 1.36
Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes. Exp Neurol (2004) 1.36
Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block. J Physiol (2007) 1.34
Mechanism of partial agonism at NMDA receptors for a conformationally restricted glutamate analog. J Neurosci (2005) 1.33
New advances in NMDA receptor pharmacology. Trends Pharmacol Sci (2011) 1.32
Mining biomarkers in human sera using proteomic tools. Proteomics (2004) 1.30
Structural aspects of AMPA receptor activation, desensitization and deactivation. Curr Opin Neurobiol (2007) 1.30
Multiple trafficking signals regulate kainate receptor KA2 subunit surface expression. J Neurosci (2003) 1.29
Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study. Arch Intern Med (2008) 1.28
Conserved structural and functional control of N-methyl-D-aspartate receptor gating by transmembrane domain M3. J Biol Chem (2005) 1.27
Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors. Nat Commun (2011) 1.26
The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages. Endocrinology (2006) 1.26
Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma (2004) 1.25
Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes. J Physiol (2007) 1.24
Subunit-selective allosteric inhibition of glycine binding to NMDA receptors. J Neurosci (2012) 1.22
Bestrophin-1 encodes for the Ca2+-activated anion channel in hippocampal astrocytes. J Neurosci (2009) 1.22
Protons trap NR1/NR2B NMDA receptors in a nonconducting state. J Neurosci (2005) 1.21
Effect of epithelial retention and removal on riboflavin absorption in porcine corneas. J Refract Surg (2009) 1.21
Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth. Cancer Res (2004) 1.21
Activation of protease-activated receptor-1 triggers astrogliosis after brain injury. J Neurosci (2005) 1.21
Assessment of delirium in the intensive care unit: nursing practices and perceptions. Am J Crit Care (2008) 1.21
Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists. J Med Chem (2010) 1.20
A norovirus intervariant GII.4 recombinant in Victoria, Australia, June 2016: the next epidemic variant? Euro Surveill (2016) 1.20
Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling. Mol Pharmacol (2005) 1.20
Structural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptors. J Neurosci (2010) 1.18
Allosteric interaction between zinc and glutamate binding domains on NR2A causes desensitization of NMDA receptors. J Physiol (2005) 1.18
Insulin-like growth factor-1 modulation of CaV1.3 calcium channels depends on Ca2+ release from IP3-sensitive stores and calcium/calmodulin kinase II phosphorylation of the alpha1 subunit EF hand. J Neurosci (2006) 1.18
Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors. J Neurosci (2011) 1.18
AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease. J Gene Med (2006) 1.17